Article Archive
Aureus launches AurPROFILER
1 September 2008
ReceptorBio signs deal to develop Telik's IRAs
1 September 2008
Strong Ph III data on Remoxy
1 September 2008
TheraQuest's TQ-1019 shows sustained efficacy in animals
1 September 2008
Mundipharma's Targin fares well vs oxycodone
1 September 2008
Bayer signs deal to supply contraceptives to developing nations
1 September 2008
Thomson releases Pharma Matters reports for 1st qtr
1 September 2008
KV to use Acrux' spray for six new products
1 September 2008
Rumors of takeover bid for Omrix
1 September 2008
Avantogen completes private placement
1 September 2008
India plans cheap drug stores for the poor
1 September 2008
Ligand reports second quarter in loss
1 September 2008
Vivus returns to profit on Evamist gain
1 September 2008
Pipex acquires novel RA mid-stage candidate
1 September 2008
B-MS licenses PDL's MM drug for $30M up front
1 September 2008
Thailand "will not end" compulsory licenses
1 September 2008
MDT close to leprosy eradication
1 September 2008
US FDA set for even fewer approvals in 2008
1 September 2008
Big donors distort health services in developing countries
1 September 2008
NEJM editors side against Wyeth
1 September 2008
US seasonal flu vaccine ships early
1 September 2008
Qiagen and Idaho Tech settle patent dispute
1 September 2008
Higher dose of Pfizer's Lipitor may reduce risk of heart attack
1 September 2008
Antibodies from GM silkworms 10% cheaper to produce
1 September 2008
BTG to receive $7M PH III trial milestone from Tolerx
1 September 2008
EU and US regulators approve pivotal Ph III telaprevir trial
1 September 2008
Neurologix' Ph II trial PD gene therapy gets go-ahead
1 September 2008
52-week improvements with VEGF Trap-Eye
1 September 2008
Vical's Vaxfectin to be studied for HIV DNA vacc
1 September 2008
Qiagen introduces HLA-B*5701 test
1 September 2008
Invitrogen launches new legionella test
1 September 2008
Medarex' loss deepens on charges in 2nd qtr
1 September 2008
Eden and HGS enter marketing agreement
1 September 2008
Stora Enso to produce Sharp's new Pharma DDS packaging
1 September 2008
Novelos closes $3M private funding round
1 September 2008
BN enters into prostate cancer R&D deal with US NCI
1 September 2008
FDA forces label-change for Amgen anemia drugs
1 September 2008
Role for miR-21 in regulating certain cancer cells
1 September 2008
MDRNA licenses Uni of Michigan IP
1 September 2008
Urigen granted key US patent for PBS drug
1 September 2008
Onyx back in profit for 2nd qtr after sales jump
1 September 2008
Ziopharm granted key indibulin US and European patents
1 September 2008
EMEA grants Ranexa brand name
1 September 2008
US drugmakers' reputation goes from bad to worse
1 September 2008
Alnylam on track to file IND for ALN-VSP by year end
1 September 2008
Strong Ph III data on Dyax' HAE drug; submission due in 4th qtr
1 September 2008
Access licenses MuGard to Milestone Biosci
1 September 2008
EMEA accepts MAA for Introgen's Advexin
1 September 2008
Salix announces $50M note offering
1 September 2008
On-line Rx drug shopping can be safe
1 September 2008
Oxford BioMedica rejects takeover bid
1 September 2008
Virtual pediatric clinical trials to become routine
1 September 2008
GPC narrows 2nd-qtr loss after restructuring
1 September 2008
Biota defends Relenza settlement with GSK
1 September 2008
Algeta's 2nd-qtr deepens loss
1 September 2008
Speedel's 2nd-qtr 2008 loss improves 13%
1 September 2008
Crucell's 2nd-qtr results beat expectations
1 September 2008
SYGNIS loss increases for 1st-qtr 2008
1 September 2008
Lundbeck profit down 52% on Flurizan failure
1 September 2008
UK NICE's recommendation on J&J's and S-P's Remicade analyzed
1 September 2008
Affymetrix' SNP arrays aid in schizo CNV mapping
1 September 2008
Orphan status for Santhera's Omigapil
1 September 2008
China Sky One nasal spray for rheumatic disease
1 September 2008
Positive Ph Ib data for Nuevelo anticoagulant
1 September 2008
Australia's TGA settles with Pan Pharma
1 September 2008
$3.8M grant to study cethromycin in bioterror defense
1 September 2008
Strong Ph II HRPC data on Antisoma's VDA
1 September 2008
Versatis recommended for PHN in Scotland
1 September 2008
Call for AIDS "syrups" from MSF
1 September 2008
China's Huifeng Bio posts record results
1 September 2008
French agency gets $10M grant from Gates
1 September 2008
PhRMA slams US state of Mass law
1 September 2008
US PMB sees lowest Rx spend growth
1 September 2008
Lilly pays BioMS $10M as MS trial continues
1 September 2008
Big immune response with nasal HBV vacc
1 September 2008
Lovastatin achieves melanoma remission
1 September 2008
Symbicort sees similar safety to budesonide
1 September 2008
AstraZeneca enters partnership with Singapore institutions for R&D of novel HCC therapies
1 September 2008
AstraZeneca's Crestor to be co-promoted with Abbott Labs in USA
1 September 2008
Roche sells four prods to Meda for $180M
1 September 2008
Protherics rockets on bid approaches
1 September 2008
Germany's Stada on acquisitoin trail
1 September 2008
Fake drugs bought as last resort in Ivory Coast
18 August 2008
Faster avian flu test boosts vaccine efficacy
18 August 2008
Japan stock market week to Aug 11, 2008
18 August 2008
Karo Bio's first-half 2008 loss improves 14%
18 August 2008
Mylan swings to a 2nd-qtr 2008 loss on Merck
18 August 2008
Barr's 2nd-qtr 2008 profit rises 27%
18 August 2008
US gang ran 70 illegal on-line pharmacies
18 August 2008
Ore Pharma gets rights to second Roche drug
18 August 2008
EMEA assessing data on Tysabri
18 August 2008
Correction: Actelion's Tracleer
18 August 2008
AEterna Zentaris promotes Jurgen Engel to president and CEO
18 August 2008
John Kilgour joins Novis as exec VP, sales and marketing
18 August 2008
Kurt Jarnagin becomes VP biologic research as Anacor Pharma
18 August 2008
Fresenius Kabi to invest in Indian acquisition, Dabur Pharma
18 August 2008
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
